| |
Leader for New Ziment Division
IMAP Research, the new multi-client studies division of The Ziment Group announced on Friday, will have Mike Kelly as its first President. Kelly's previous work includes roles at Merck, Johnson & Johnson and TargetRx.
Kelly has over 15 years of experience in the pharmaceutical and healthcare industries including marketing, market research and sales leadership roles. Most recently, he ran a private consulting practice advising pharmaceutical and biotechnology companies on MR needs for key brands nearing launch. He starts at IMAP on December 1st.
Ziment, the global healthcare research brand for The Kantar Group, is online at www.ziment.com
|
